AVN-322
/ AllaChem, Avineuro
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 06, 2020
Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia.
(PubMed, Neuropsychiatr Dis Treat)
- "SGS-518, ABT-354, Lu AE58054, SB-742,457, S-518, AVN-211, AVN-322, SYN-114 and SYN-120 are serotonin 6 receptor antagonists and aripiprazole-controlled release serotonin 7 receptor agonists under clinical trial for schizophrenia. Thus, research on novel drugs that act on serotonin 6 and 7 receptors likely facilitates the intervention into schizophrenia patients seeking better quality of life in the future."
Journal • Review • CNS Disorders • Psychiatry • Schizophrenia
1 to 1
Of
1
Go to page
1